374 related articles for article (PubMed ID: 15753413)
1. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
Roed HG; Langkilde A; Sellebjerg F; Lauritzen M; Bang P; Mørup A; Frederiksen JL
Neurology; 2005 Mar; 64(5):804-10. PubMed ID: 15753413
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Sühs KW; Hein K; Sättler MB; Görlitz A; Ciupka C; Scholz K; Käsmann-Kellner B; Papanagiotou P; Schäffler N; Restemeyer C; Bittersohl D; Hassenstein A; Seitz B; Reith W; Fassbender K; Hilgers R; Heesen C; Bähr M; Diem R
Ann Neurol; 2012 Aug; 72(2):199-210. PubMed ID: 22926853
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neuroprotective qualities of brimonidine during LASIK.
McCarty TM; Hardten DR; Anderson NJ; Rosheim K; Samuelson TW
Ophthalmology; 2003 Aug; 110(8):1615-25. PubMed ID: 12917182
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
Tsakiri A; Kallenbach K; Fuglø D; Wanscher B; Larsson H; Frederiksen J
Mult Scler; 2012 Jan; 18(1):72-81. PubMed ID: 21921071
[TBL] [Abstract][Full Text] [Related]
9. [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].
Lüke C; Dohmen C; Dietlein TS; Brunner R; Lüke M; Krieglstein GK
Klin Monbl Augenheilkd; 2007 Dec; 224(12):932-4. PubMed ID: 18260057
[TBL] [Abstract][Full Text] [Related]
10. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome.
Kupersmith MJ; Gal RL; Beck RW; Xing D; Miller N;
Neurology; 2007 Aug; 69(6):508-14. PubMed ID: 17679669
[TBL] [Abstract][Full Text] [Related]
11. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
Kolbe S; Chapman C; Nguyen T; Bajraszewski C; Johnston L; Kean M; Mitchell P; Paine M; Butzkueven H; Kilpatrick T; Egan G
Neuroimage; 2009 Apr; 45(3):679-86. PubMed ID: 19162205
[TBL] [Abstract][Full Text] [Related]
12. Color vision defect type and spatial vision in the optic neuritis treatment trial.
Schneck ME; Haegerstrom-Portnoy G
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
[TBL] [Abstract][Full Text] [Related]
13. Early factors associated with axonal loss after optic neuritis.
Henderson AP; Altmann DR; Trip SA; Miszkiel KA; Schlottmann PG; Jones SJ; Garway-Heath DF; Plant GT; Miller DH
Ann Neurol; 2011 Dec; 70(6):955-63. PubMed ID: 22190367
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
15. Follow-up studies on pattern reversal visually evoked cortical potentials in a 2-year-old child with optic neuritis.
Sato K; Adachi-Usami E; Mizota A
J Neuroophthalmol; 1998 Mar; 18(1):21-4. PubMed ID: 9532534
[TBL] [Abstract][Full Text] [Related]
16. Optic neuritis: correlation of pain and magnetic resonance imaging.
Fazzone HE; Lefton DR; Kupersmith MJ
Ophthalmology; 2003 Aug; 110(8):1646-9. PubMed ID: 12917187
[TBL] [Abstract][Full Text] [Related]
17. [Acute optic neuritis: clinical and MRI prognostic factors. Study of fifty patients].
Deschamps R; Gout O; Fontaine B; Rigolet MH; Cabanis EA; Lyon-Caen O; Tourbah A
Rev Neurol (Paris); 2002 Apr; 158(4):446-52. PubMed ID: 11984487
[TBL] [Abstract][Full Text] [Related]
18. [Short-term effect of megadose steroid therapy in optic neuritis].
Gerling J; Kommerell G
Klin Monbl Augenheilkd; 1992 Dec; 201(6):375-80. PubMed ID: 1287359
[TBL] [Abstract][Full Text] [Related]
19. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
